320 related articles for article (PubMed ID: 28867578)
21. Long-term follow-up of intracerebroventricular injection of streptozotocin-inducing pain sensitization.
Rostami F; Abbasi Z; Fereidoni M
Behav Pharmacol; 2022 Dec; 33(8):542-550. PubMed ID: 36256700
[TBL] [Abstract][Full Text] [Related]
22. The Role of Zinc Status on Spatial Memory, Hippocampal Synaptic Plasticity, and Insulin Signaling in icv-STZ-Induced Sporadic Alzheimer's-Like Disease in Rats.
Baltaci SB; Unal O; Gulbahce-Mutlu E; Gumus H; Pehlivanoglu S; Yardimci A; Mogulkoc R; Baltaci AK
Biol Trace Elem Res; 2022 Sep; 200(9):4068-4078. PubMed ID: 34727320
[TBL] [Abstract][Full Text] [Related]
23. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model.
Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY
Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592
[TBL] [Abstract][Full Text] [Related]
24. Early time course of oxidative stress in hippocampal synaptosomes and cognitive loss following impaired insulin signaling in rats: Development of sporadic Alzheimer's disease.
Ansari MA; Rao MS; Al-Jarallah A; Babiker FM
Brain Res; 2023 Jan; 1798():148134. PubMed ID: 36328067
[TBL] [Abstract][Full Text] [Related]
25. Paeonol Ameliorates Cognitive Deficits in Streptozotocin Murine Model of Sporadic Alzheimer's Disease via Attenuation of Oxidative Stress, Inflammation, and Mitochondrial Dysfunction.
Tayanloo-Beik A; Kiasalari Z; Roghani M
J Mol Neurosci; 2022 Feb; 72(2):336-348. PubMed ID: 34797511
[TBL] [Abstract][Full Text] [Related]
26. Intermittent theta burst stimulation ameliorates cognitive impairment and hippocampal gliosis in the Streptozotocin-induced model of Alzheimer's disease.
Stanojevic J; Dragic M; Stevanovic I; Ilic T; Stojanovic I; Zeljkovic M; Ninkovic M
Behav Brain Res; 2022 Sep; 433():113984. PubMed ID: 35780960
[TBL] [Abstract][Full Text] [Related]
27. Insulin/IGF signaling-related gene expression in the brain of a sporadic Alzheimer's disease monkey model induced by intracerebroventricular injection of streptozotocin.
Lee Y; Kim YH; Park SJ; Huh JW; Kim SH; Kim SU; Kim JS; Jeong KJ; Lee KM; Hong Y; Lee SR; Chang KT
J Alzheimers Dis; 2014; 38(2):251-67. PubMed ID: 23948941
[TBL] [Abstract][Full Text] [Related]
28. Effect of acute lipopolysaccharide-induced inflammation in intracerebroventricular-streptozotocin injected rats.
Murtishaw AS; Heaney CF; Bolton MM; Sabbagh JJ; Langhardt MA; Kinney JW
Neuropharmacology; 2016 Feb; 101():110-22. PubMed ID: 26327677
[TBL] [Abstract][Full Text] [Related]
29. Central cholinergic function and metabolic changes in streptozotocin-induced rat brain injury.
Yuliani T; Lobentanzer S; Klein J
J Neurochem; 2021 Sep; 158(6):1307-1319. PubMed ID: 33448390
[TBL] [Abstract][Full Text] [Related]
30. Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.
Dos Santos JPA; Vizuete A; Hansen F; Biasibetti R; Gonçalves CA
J Alzheimers Dis; 2018; 61(1):237-249. PubMed ID: 29154269
[TBL] [Abstract][Full Text] [Related]
31. Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model.
Khan MB; Khan MM; Khan A; Ahmed ME; Ishrat T; Tabassum R; Vaibhav K; Ahmad A; Islam F
Neurochem Int; 2012 Dec; 61(7):1081-93. PubMed ID: 22898296
[TBL] [Abstract][Full Text] [Related]
32. Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats.
Solmaz V; Çınar BP; Yiğittürk G; Çavuşoğlu T; Taşkıran D; Erbaş O
Eur J Pharmacol; 2015 Oct; 765():482-7. PubMed ID: 26386291
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of 5-HT
Afshar S; Shahidi S; Rohani AH; Soleimani Asl S; Komaki A
J Chem Neuroanat; 2019 Mar; 96():140-147. PubMed ID: 30684605
[TBL] [Abstract][Full Text] [Related]
34. Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease.
Kazkayasi I; Telli G; Nemutlu E; Uma S
Life Sci; 2022 Jun; 299():120538. PubMed ID: 35395244
[TBL] [Abstract][Full Text] [Related]
35. Intranasal deferoxamine affects memory loss, oxidation, and the insulin pathway in the streptozotocin rat model of Alzheimer's disease.
Fine JM; Forsberg AC; Stroebel BM; Faltesek KA; Verden DR; Hamel KA; Raney EB; Crow JM; Haase LR; Knutzen KE; Kaczmarczek KD; Frey WH; Hanson LR
J Neurol Sci; 2017 Sep; 380():164-171. PubMed ID: 28870559
[TBL] [Abstract][Full Text] [Related]
36. Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.
Ponce-Lopez T; Liy-Salmeron G; Hong E; Meneses A
Brain Res; 2011 Dec; 1426():73-85. PubMed ID: 22036080
[TBL] [Abstract][Full Text] [Related]
37. Determination of the Best Concentration of Streptozotocin to Create a Diabetic Brain Using Histological Techniques.
Dehghan-Shasaltaneh M; Naghdi N; Choopani S; Alizadeh L; Bolouri B; Masoudi-Nejad A; Riazi GH
J Mol Neurosci; 2016 May; 59(1):24-35. PubMed ID: 26790434
[TBL] [Abstract][Full Text] [Related]
38. Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.
Li D; Huang Y; Cheng B; Su J; Zhou WX; Zhang YX
J Alzheimers Dis; 2016 Jul; 54(1):89-98. PubMed ID: 27472873
[TBL] [Abstract][Full Text] [Related]
39. Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?
Knezovic A; Loncar A; Homolak J; Smailovic U; Osmanovic Barilar J; Ganoci L; Bozina N; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2017 Jun; 124(6):695-708. PubMed ID: 28470423
[TBL] [Abstract][Full Text] [Related]
40. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.
Akhtar A; Dhaliwal J; Saroj P; Uniyal A; Bishnoi M; Sah SP
Inflammopharmacology; 2020 Apr; 28(2):385-400. PubMed ID: 31898080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
